Pyoderma gangrenosum induced by secukinumab in a patient with psoriasis successfully treated with ustekinumab
Main Authors: | Amy J. Petty, BS, Melodi J. Whitley, MD, PhD, Alexandra Balaban, MD, Kenneth Ellington, MD, Anne L. Marano, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512620304306 |
Similar Items
-
Successful long‐term treatment of pyoderma gangrenosum with secukinumab
by: Fabienne Froehlich, et al.
Published: (2023-06-01) -
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease
by: Klaudia Miklusiak, et al.
Published: (2023-05-01) -
Secukinumab in psoriasis patients with prior ustekinumab treatment: Results of a single-center experience
by: Ting-Shun Wang, et al.
Published: (2017-03-01) -
Ustekinumab for pyoderma gangrenosum–like skin ulcerations in late-onset leukocyte adhesion deficiency
by: Florian Schmid, MD, et al.
Published: (2024-05-01) -
Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)
by: Jerry Bagel, et al.
Published: (2018-10-01)